Bulk and single-cell RNA-sequencing analyses along with abundant machine learning methods identify a novel monocyte signature in SKCM

Abstract

BackgroundGlobal patterns of immune cell communications in the immune microenvironment of skin cutaneous melanoma (SKCM) haven’t been well understood. Here we recognized signaling roles of immune cell populations and main contributive signals. We explored how multiple immune cells and signal paths coordinate with each other and established a prognosis signature based on the key specific biomarkers with cellular communication.MethodsThe single-cell RNA sequencing (scRNA-seq) dataset was downloaded from the Gene Expression Omnibus (GEO) database, in which various immune cells were extracted and re-annotated according to cell markers defined in the original study to identify their specific signs. We computed immune-cell communication networks by calculating the linking number or summarizing the communication probability to visualize the cross-talk tendency in different immune cells. Combining abundant analyses of communication networks and identifications of communication modes, all networks were quantitatively characterized and compared. Based on the bulk RNA sequencing data, we trained specific markers of hub communication cells through integration programs of machine learning to develop new immune-related prognostic combinations.ResultsAn eight-gene monocyte-related signature (MRS) has been built, confirmed as an independent risk factor for disease-specific survival (DSS). MRS has great predictive values in progression free survival (PFS) and possesses better accuracy than traditional clinical variables and molecular features. The low-risk group has better immune functions, infiltrated with more lymphocytes and M1 macrophages, with higher expressions of HLA, immune checkpoints, chemokines and costimulatory molecules. The pathway analysis based on seven databases confirms the biological uniqueness of the two risk groups. Additionally, the regulon activity profiles of 18 transcription factors highlight possible differential regulatory patterns between the two risk groups, suggesting epigenetic event-driven transcriptional networks may be an important distinction. MRS has been identified as a powerful tool to benefit SKCM patients. Moreover, the IFITM3 gene has been identified as the key gene, validated to express highly at the protein level via the immunohistochemical assay in SKCM.ConclusionMRS is accurate and specific in evaluating SKCM patients’ clinical outcomes. IFITM3 is a potential biomarker. Moreover, they are promising to improve the prognosis of SKCM patients.

Comprehensive analysis of macrophage-related genes in prostate cancer by integrated analysis of single-cell and bulk RNA sequencing

“…Generally, if two gene products have similar functions, they will have high semantic similarity and have close gene ontology term trees [38]. Based on the "mgeneSim" function, which measures similarity by computing the geometric mean of molecular functions and cellular components, we assessed the significance of each gene to other genes in the signature by calculating the average similarity [39].…”

An unbiased approach of molecular characterization of the endometrium: toward defining endometrial-based infertility

“…The TCGA (Cancer Genome Atlas) project, started in 2005, generated comprehensive molecular profiles of different types of cancer ( The Cancer Genome Atlas, 2005 ; Tomczak et al , 2015 ). Molecular profiling has transformed cancer treatment by guiding the selection of targeted therapies, identifying biomarkers, understanding resistance mechanisms, guiding the use of immunotherapies and facilitating clinical trials ( Lee et al , 2018 ; Liu et al , 2023 ; Sahm et al , 2023 ; Saito-Adachi et al , 2023 ). This personalized approach has improved treatment outcomes and reduced unnecessary side effects.…”

Dermoscopy-based Radiomics Help Distinguish Basal Cell Carcinoma and Actinic Keratosis: A Large-scale Real-world Study Based on a 207-combination Machine Learning Computational Framework

“…Deep learning (DL) neural networks exemplify the successful integration of artificial intelligence's automated processing into clinical practice, showcasing outstanding performance in tasks like image processing and classification, including applications in ultrasound and CT (computerised tomography) 26 - 28 . Research indicates that the classification ability of deep neural networks for dermoscopic images can rival that of dermatologists 29 .…”

“…In recent years, machine learning has been extensively applied to structured data in genomics — particularly cancer genomics, where it is employed to identify and analyse pathogenic mutations. 28 , 30 , 31 . Machine learning algorithms, with the aid of automated computer analysis, can learn from input data and optimise algorithmic combinations along with their parameters.…”